The ideal pleural sclerosing agent should be easily administered, with
out significant side effects, inexpensive, and widely available, None
of the agents presently used meets all of these criteria, Ethanolamine
oleate (ETH) is a sclerosing agent used in the sclerotherapy treatmen
t of varicose veins of the legs and esophagus, The objective of the pr
esent study was to assess the efficacy of ETH as a pleural sclerosant
in rabbits, An additional objective was to assess if better results we
re obtained when dextrose 500% (D50) as opposed to saline was used as
the diluent, Each group of 10 rabbits received a total volume of 2 ml
intrapleurally, The eight treatments were as follows: (1) 2 mi saline;
(2) 2 mi D50; (3) 25 mg ETH plus 1.5 ml saline; (4) 25 mg ETH plus 1.
5 mi D50; (5) 50 mg ETH plus 1.0 ml saline; (6) 50 mg ETH plus 1 mi D5
0; (7) 75 mg ETH plus 0.5 ml D50, and (8) 100 mg ETH, The rabbits were
sacrificed 28 days after the injection, The intrapleural instillation
of ETH resulted in evident pleurodesis, which was dose-dependent; 100
mg ETH induced significantly (p < 0.05) more adhesions than did any o
ther treatment, The selection of the diluent had no effect on the pleu
rodesis, The microscopic examination of the right visceral pleura show
ed that the mean degree of fibrosis after 100 mg ETH was significantly
(p < 0.05) greater than that after the other solutions, The mean degr
ee of pleural inflammation, lung inflammation and lung fibrosis was mi
nimal in all the groups, From this study we conclude that undiluted ET
H produces pleurodesis in our experimental model, At the doses used, t
he pleurodesis was less than that produced after talc, tetracycline de
rivatives or silver nitrate in the same model.